Covid-19 Vaccination Options for Immunosuppressed Cancer Patients

Background: Currently, many COVID-19 vaccine candidates are being developed to end the pandemic; however, immunosuppressed cancer patients have been excluded from the participating criteria. It is important that they are able to examine their options for achieving immunity against COVID-19. Purpose:...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	I Dewa Agung Panji Dwipayana, I Dewa Ayu Agung Diah Sutarini
Formato:	article
Lenguaje:	EN ID
Publicado:	Universitas Airlangga 2021
Materias:	covid-19 vaccine immunization immunosuppressed cancer Public aspects of medicine RA1-1270 Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/c1e02e44d14e4d388e5806a9bfb666a2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c1e02e44d14e4d388e5806a9bfb666a2
record_format	dspace
spelling	oai:doaj.org-article:c1e02e44d14e4d388e5806a9bfb666a22021-12-02T11:53:59ZCovid-19 Vaccination Options for Immunosuppressed Cancer Patients2301-71712541-092X10.20473/jbe.V9I12021.1-9https://doaj.org/article/c1e02e44d14e4d388e5806a9bfb666a22021-01-01T00:00:00Zhttps://e-journal.unair.ac.id/JBE/article/view/22600https://doaj.org/toc/2301-7171https://doaj.org/toc/2541-092XBackground: Currently, many COVID-19 vaccine candidates are being developed to end the pandemic; however, immunosuppressed cancer patients have been excluded from the participating criteria. It is important that they are able to examine their options for achieving immunity against COVID-19. Purpose: This review aims to discuss the available options that can be taken to vaccinate immunosuppressed cancer patients when no vaccine is being developed for their safety. Method: A literature study was conducted using Google Scholar, DOAJ, and GARUDA Library on November 2, 2020, focusing on articles examining vaccination guidelines for immunosuppressed cancer patients. Results: The search found 200 articles, which were curated to obtain 13 articles that satisfied all inclusion criteria. These consist of four guidelines, five reviews, and four research articles. Based on the literature, immunosuppressed cancer patients have the option to use the vaccines currently under development, with precautions set for live attenuated and potentially infectious vaccines. Vaccination timing also needs to be adjusted so as to fall at a certain time before or after the immunosuppressive condition. Moreover, a more complete COVID-19 immunity can be achieved through a synergy between individual vaccination and the construction of herd immunity. Conclusion: Most of the vaccines currently under development may be safe for cancer patients, being mindful of several considerations. Here, herd immunity can serve as a complement to individual immunity.I Dewa Agung Panji DwipayanaI Dewa Ayu Agung Diah SutariniUniversitas Airlanggaarticlecovid-19vaccineimmunizationimmunosuppressedcancerPublic aspects of medicineRA1-1270Infectious and parasitic diseasesRC109-216ENIDJurnal Berkala Epidemiologi, Vol 9, Iss 1, Pp 1-9 (2021)
institution	DOAJ
collection	DOAJ
language	EN ID
topic	covid-19 vaccine immunization immunosuppressed cancer Public aspects of medicine RA1-1270 Infectious and parasitic diseases RC109-216
spellingShingle	covid-19 vaccine immunization immunosuppressed cancer Public aspects of medicine RA1-1270 Infectious and parasitic diseases RC109-216 I Dewa Agung Panji Dwipayana I Dewa Ayu Agung Diah Sutarini Covid-19 Vaccination Options for Immunosuppressed Cancer Patients
description	Background: Currently, many COVID-19 vaccine candidates are being developed to end the pandemic; however, immunosuppressed cancer patients have been excluded from the participating criteria. It is important that they are able to examine their options for achieving immunity against COVID-19. Purpose: This review aims to discuss the available options that can be taken to vaccinate immunosuppressed cancer patients when no vaccine is being developed for their safety. Method: A literature study was conducted using Google Scholar, DOAJ, and GARUDA Library on November 2, 2020, focusing on articles examining vaccination guidelines for immunosuppressed cancer patients. Results: The search found 200 articles, which were curated to obtain 13 articles that satisfied all inclusion criteria. These consist of four guidelines, five reviews, and four research articles. Based on the literature, immunosuppressed cancer patients have the option to use the vaccines currently under development, with precautions set for live attenuated and potentially infectious vaccines. Vaccination timing also needs to be adjusted so as to fall at a certain time before or after the immunosuppressive condition. Moreover, a more complete COVID-19 immunity can be achieved through a synergy between individual vaccination and the construction of herd immunity. Conclusion: Most of the vaccines currently under development may be safe for cancer patients, being mindful of several considerations. Here, herd immunity can serve as a complement to individual immunity.
format	article
author	I Dewa Agung Panji Dwipayana I Dewa Ayu Agung Diah Sutarini
author_facet	I Dewa Agung Panji Dwipayana I Dewa Ayu Agung Diah Sutarini
author_sort	I Dewa Agung Panji Dwipayana
title	Covid-19 Vaccination Options for Immunosuppressed Cancer Patients
title_short	Covid-19 Vaccination Options for Immunosuppressed Cancer Patients
title_full	Covid-19 Vaccination Options for Immunosuppressed Cancer Patients
title_fullStr	Covid-19 Vaccination Options for Immunosuppressed Cancer Patients
title_full_unstemmed	Covid-19 Vaccination Options for Immunosuppressed Cancer Patients
title_sort	covid-19 vaccination options for immunosuppressed cancer patients
publisher	Universitas Airlangga
publishDate	2021
url	https://doaj.org/article/c1e02e44d14e4d388e5806a9bfb666a2
work_keys_str_mv	AT idewaagungpanjidwipayana covid19vaccinationoptionsforimmunosuppressedcancerpatients AT idewaayuagungdiahsutarini covid19vaccinationoptionsforimmunosuppressedcancerpatients
_version_	1718394832732291072

Covid-19 Vaccination Options for Immunosuppressed Cancer Patients

Ejemplares similares